NCT03275909

Brief Summary

Background: The chronic phase of schizophrenia (CS) that extremely affects the way people think, feel and act, underlines the need for effective interventions in patients affected by this disorder. The Integrated Psychological Therapy appears in clinical practice guidelines as the reference therapy in the treatment of this type of patients. In this paper authors propose to include in this program a new module focused on Emotional Management Therapy in order to reinforce its effectiveness. The aim of this study is to describe the design of a study protocol for a randomized controlled trial in which the objective is to assess the efficacy of this modified IPT program in patients with CS compared to treatment as usual (pharmacological treatment and social and leisure activities in a Day Care Center). Methods/design: This is a randomized study with pre and post-treatment assessment and with a 6- and 12-month follow-up. Patients are to be randomly assigned to one of two treatments: (1) a experimental group: integrated psychological therapy in conjunction with emotional management therapy (IPT+EMT), composed of 2-hour biweekly 60 group sessions for 32 weeks, in addition to the treatment as usual (TAU), or (2) a control group (treatment as usual). Participants in both groups will be evaluated at baseline (pre-treatment) and at post-treatment after 8 months. The primary outcome will be that patients in the experimental group will show a greater improvement over participants in the control group in reducing symptoms and increasing emotional abilities, as well as in improving their quality of life. The secondary outcome will be that these results will maintain at the 6- and 12-month follow-up in the experimental group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2011

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2013

Completed
2.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 10, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 8, 2017

Completed
Last Updated

September 8, 2017

Status Verified

September 1, 2017

Enrollment Period

2.1 years

First QC Date

July 10, 2017

Last Update Submit

September 7, 2017

Conditions

Keywords

Chronic schizophreniaEmotional Management TherapyIntegrated Psychological Therapy

Outcome Measures

Primary Outcomes (1)

  • Frankfurt Complaint Questionnaire (FBF-3)

    (Assessing change)This is a self-report test composed of 98 items measuring the presence of the "basic" symptoms of schizophrenia. These are subjectively experienced disturbances at different domains including perception, thought, processing, language and attention that it could be the neurobiological features of schizophrenia. It contains 10 subscales and 4 factors. We will use a validated version for the Spanish population, in which Cronbach's alpha was above .95 and the test-retest reliability was above .60

    Pretreatment-Posttreatment (8months)-1 month-3 months-6 months-12 months follow-up

Secondary Outcomes (5)

  • Screen for Cognitive Impairment in Psychiatry (SCIP)

    Pretreatment-Posttreatment (8 months)-1 month-3 months-6 months-12 months follow-up

  • Wechsler Adult Intelligence Scale-Third Edition (WAIS-III)

    Pretreatment-Posttreatment (8 months)-1 month-3 months-6 months-12 months follow-up

  • Wisconsin Card Sorting Test (WCST)

    Pretreatment-Posttreatment (8 months)-1 month-3 months-6 months-12 months follow-up

  • Social Functioning Scale (SFS)

    Pretreatment-Posttreatment-1 month (8 months)-3 months-6 months-12 months follow-up

  • Lancashire Quality of Life Profile (LQoLP)

    Pretreatment-Posttreatment (8 months)-1 month-3 months-6 months-12 months follow-up

Study Arms (2)

Study procedure

EXPERIMENTAL

An experimental group the psychological treatment includes 50 sessions of integrated psychological therapy (IPT) (focused on attentional skills training, social perception skills training, verbal communication skills, social skills training, interpersonal problems solving skills) and 10 sessions of specific emotional management therapy (EMT), designed for this research and based on the contents developed by Hodel, Kern and Brenner.

Behavioral: Integrated Psychological Therapy

Treatment as usual

NO INTERVENTION

The treatment as usual is pharmacological treatment and activities in a Day Care Center.

Interventions

The psychological treatment includes 50 sessions of integrated psychological therapy focused on attentional skills, social perception skills, verbal communication skills, social skills and interpersonal problems solving skills and 10 sessions of specific emotional management therapy , designed for this research. and based on the contents developed by Hodel, Kern and Brenner

Also known as: Emotional Management Therapy
Study procedure

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having ≥ 5 years since disease onset and aged between 25 and 65 years.
  • Being in a stable phase of the illness and under psychopharmacological treatment.
  • Having negative or attenuated positive symptoms.
  • Failing to achieve premorbid functioning in terms of education, work and/or social life.
  • Agreeing to participate in the study and giving written informed consent.

You may not qualify if:

  • \. Presenting organic brain pathology. 2. Presenting intellectual developmental disorder according to DSM-5 criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Karmele Salaberria, Ph.D

    Lecturer of School of Psychology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Phd.-Lecturer

Study Record Dates

First Submitted

July 10, 2017

First Posted

September 8, 2017

Study Start

July 1, 2011

Primary Completion

July 30, 2013

Study Completion

December 31, 2015

Last Updated

September 8, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will share

to share the study protocol and the clinical study report

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
2011/2017
Access Criteria
Researchers